Business profile not generated.
Run python -m application.cli.business_profile run --market US --one HOOK, then regenerate the site.
Issue 000 | U.S. Pilot | US
HOOK
HOOKIPA Pharma Inc.
Needs Review
Stale Filing
10-Q | 2025-05-15
Filing currency: USD
Margin of Safety
56.2%
GNNI internal calculation. Market context inputs are retained internally and are not displayed.
- Current Assets
- 60,091,000USD
- Total Liabilities
- 27,176,000USD
- NCAV
- 32,915,000USD
- Cash
- 40,276,000USD
- NCAV per share
- 2.62USD/share
- Evidence
- 6 annual | 20 quarterly
Business Profile
Checklist-driven facts extracted from filing text. Missing fields stay visible.
Known Unknowns
Medium | Share Count
Issue 000 does not yet evaluate share count trend or post-filing dilution beyond Mary's screening flags.
Low | Classification
U.S. Pilot rows are surfaced for source inspection and may still need manual business classification review.
Medium | Filing
Some rows are based on older filing data and require manual freshness review.
Annual Financials
Latest annual periods, newest first. Missing cells render as n/a.
| Metric |
2024-12-31
10-K
USD
|
2023-12-31
10-K
USD
|
2022-12-31
10-K
USD
|
2021-12-31
10-K
USD
|
2020-12-31
10-K
USD
|
2019-12-31
10-K
USD
|
|---|---|---|---|---|---|---|
| Revenue | 43,946,000 | 20,129,000 | 14,249,000 | 18,448,000 | 19,584,000 | 11,942,000 |
| Operating Income | -51,455,000 | -97,694,000 | -73,155,000 | -81,674,000 | -53,285,000 | -51,085,000 |
| Net Income | -43,503,000 | -81,580,000 | -64,915,000 | -75,665,000 | -44,082,000 | -43,037,000 |
| Cash From Operations | -76,978,000 | -57,524,000 | -19,997,000 | -66,016,000 | -39,339,000 | -41,731,000 |
| Capex | -194,000 | -4,159,000 | -5,017,000 | -12,581,000 | -2,371,000 | -1,999,000 |
| Free Cash Flow | -77,172,000 | -61,683,000 | -25,014,000 | -78,597,000 | -41,710,000 | -43,730,000 |
| Cash And Equivalents | 39,684,000 | 117,096,000 | 112,488,000 | 65,921,000 | 142,743,000 | 113,151,000 |
| Accounts Receivable | 290,000 | 511,000 | 6,533,000 | 6,895,000 | 5,542,000 | 1,537,000 |
| Inventory | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Current Assets | 80,665,000 | 147,116,000 | 147,196,000 | 102,135,000 | 171,504,000 | 128,017,000 |
| Total Assets | 82,545,000 | 161,337,000 | 170,454,000 | 126,045,000 | 187,817,000 | 143,745,000 |
| Total Current Liabilities | 24,653,000 | 41,988,000 | 35,632,000 | 27,654,000 | 21,143,000 | 14,755,000 |
| Total Liabilities | 31,331,000 | 71,480,000 | 67,937,000 | 36,453,000 | 31,694,000 | 25,846,000 |
| Shareholders Equity | 51,214,000 | 89,857,000 | 102,517,000 | 89,592,000 | 156,123,000 | 117,899,000 |
| Shares Outstanding | n/a | n/a | n/a | n/a | n/a | n/a |
| Shares Outstanding Diluted | n/a | n/a | n/a | n/a | n/a | n/a |
| Weighted Avg Shares Diluted | 12,538,794 | 94,526,561 | 65,512,957 | 32,833,590 | 26,039,108 | 17,859,935 |
| Weighted Avg Shares Basic | 12,538,794 | 94,526,561 | 65,512,957 | 32,833,590 | 26,039,108 | 17,859,935 |
Quarterly Financials
Latest quarterly periods, newest first. Periods are shown only when Data Vault has them.
| Metric |
2025-03-31
10-Q
USD
|
2024-12-31
10-K
USD
|
2024-09-30
10-Q
USD
|
2024-06-30
10-Q
USD
|
2024-03-31
10-Q
USD
|
2023-12-31
10-K
USD
|
2023-09-30
10-Q
USD
|
2023-06-30
10-Q
USD
|
2023-03-31
10-Q
USD
|
2022-12-31
10-K
USD
|
2022-09-30
10-Q
USD
|
2022-06-30
10-Q
USD
|
2022-03-31
10-Q
USD
|
2021-12-31
10-K
USD
|
2021-09-30
10-Q
USD
|
2021-06-30
10-Q
USD
|
2021-03-31
10-Q
USD
|
2020-12-31
10-K
USD
|
2020-09-30
10-Q
USD
|
2020-06-30
10-Q
USD
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,004,000 | 1,354,000 | 4,703,000 | 1,290,000 | 36,599,000 | 7,407,000 | 6,867,000 | 2,679,000 | 3,176,000 | 7,828,000 | 2,230,000 | 2,746,000 | 1,445,000 | 3,895,000 | 3,874,000 | 5,378,000 | 5,301,000 | 5,163,000 | 4,040,000 | 6,685,000 |
| Operating Income | -17,874,000 | 999,000 | -41,102,000 | -22,458,000 | 11,106,000 | -30,895,000 | -22,670,000 | -21,472,000 | -22,657,000 | -13,588,000 | -20,993,000 | -18,427,000 | -20,147,000 | -22,047,000 | -21,166,000 | -19,289,000 | -19,172,000 | -15,194,000 | -16,406,000 | -9,226,000 |
| Net Income | -15,427,000 | -5,855,000 | -32,936,000 | -19,095,000 | 14,383,000 | -24,818,000 | -19,066,000 | -18,016,000 | -19,680,000 | -12,311,000 | -18,280,000 | -16,356,000 | -17,968,000 | -21,235,000 | -20,039,000 | -17,153,000 | -17,238,000 | -12,474,000 | -13,590,000 | -7,092,000 |
| Cash From Operations | 52,000 | -20,938,000 | -17,508,000 | -14,376,000 | -24,156,000 | -11,224,000 | -24,119,000 | -19,333,000 | -2,848,000 | 13,137,000 | -16,508,000 | -18,359,000 | 1,733,000 | -13,243,000 | -17,644,000 | -20,732,000 | -14,397,000 | -11,301,000 | -10,365,000 | -10,545,000 |
| Capex | -20,000 | -2,000 | -31,000 | -45,000 | -116,000 | -422,000 | -3,018,000 | -445,000 | -274,000 | -599,000 | -958,000 | -1,632,000 | -1,828,000 | -5,141,000 | -2,486,000 | -4,624,000 | -330,000 | -505,000 | -625,000 | -1,042,000 |
| Free Cash Flow | 32,000 | -20,940,000 | -17,539,000 | -14,421,000 | -24,272,000 | -11,646,000 | -27,137,000 | -19,778,000 | -3,122,000 | 12,538,000 | -17,466,000 | -19,991,000 | -95,000 | -18,384,000 | -20,130,000 | -25,356,000 | -14,727,000 | -11,806,000 | -10,990,000 | -11,587,000 |
| Cash And Equivalents | 40,276,000 | 39,684,000 | 59,750,000 | 77,150,000 | 92,751,000 | 117,096,000 | 107,676,000 | 135,587,000 | 109,600,000 | 112,488,000 | 99,776,000 | 117,918,000 | 140,825,000 | 65,921,000 | 82,269,000 | 102,523,000 | 127,716,000 | 142,743,000 | 81,830,000 | 92,857,000 |
| Total Current Assets | 60,091,000 | 80,665,000 | 93,156,000 | 107,351,000 | 132,710,000 | 147,116,000 | 139,471,000 | 168,143,000 | 139,913,000 | 147,196,000 | 129,611,000 | 149,077,000 | 171,079,000 | 102,135,000 | 118,577,000 | 143,451,000 | 153,340,000 | 171,504,000 | 105,795,000 | 117,893,000 |
| Total Liabilities | 27,176,000 | 31,331,000 | 37,928,000 | 38,982,000 | 41,349,000 | 71,480,000 | 68,959,000 | 78,780,000 | 79,609,000 | 67,937,000 | 38,178,000 | 40,258,000 | 47,782,000 | 36,453,000 | 34,086,000 | 40,222,000 | 29,886,000 | 31,694,000 | 29,092,000 | 29,353,000 |
| Shares Outstanding | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Shares Outstanding Diluted | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Weighted Avg Shares Diluted | 12,544,777 | 12,538,794 | 12,538,774 | 12,538,774 | 125,976,054 | 94,526,561 | 110,388,107 | 82,705,264 | 72,217,823 | 65,512,957 | 72,230,709 | 72,195,007 | 45,040,022 | 32,833,590 | 32,874,426 | 32,804,269 | 32,766,284 | 26,039,108 | n/a | n/a |
| Weighted Avg Shares Basic | 12,544,777 | 12,538,794 | 12,538,774 | 12,538,774 | 125,388,107 | 94,526,561 | 110,388,107 | 82,705,264 | 72,217,823 | 65,512,957 | 72,230,709 | 72,195,007 | 45,040,022 | 32,833,590 | 32,874,426 | 32,804,269 | 32,766,284 | 26,039,108 | n/a | n/a |
Audit Trail
NCAV Audit
Official-source inputs remain linked to filing provenance. Derived values are labeled as such.
| Input | Value | Source concept | Filing period | Confidence | Provenance |
|---|---|---|---|---|---|
| Current Assets | 60,091,000USD | us-gaap:AssetsCurrent | 2025-03-31 | 1.00 |
sec/companyfacts/cik=0001760542/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001760542\companyfacts.json |
| Total Liabilities | 27,176,000USD | us-gaap:Liabilities | 2025-03-31 | 1.00 |
sec/companyfacts/cik=0001760542/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001760542\companyfacts.json |
| Cash | 40,276,000USD | us-gaap:CashAndCashEquivalentsAtCarryingValue | 2025-03-31 | 1.00 |
sec/companyfacts/cik=0001760542/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001760542\companyfacts.json |
| Shares Outstanding | 12,544,777 | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding | 2025-03-31 | 1.00 |
sec/companyfacts/cik=0001760542/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001760542\companyfacts.json |
| NCAV | 32,915,000USD | derived | 2025-03-31 | n/a | company-evidence-v1 | total_current_assets - total_liabilities |
| NCAV per share | 2.62USD | derived | 2025-03-31 | n/a | company-evidence-v1 | NCAV / shares_outstanding |
| Margin of Safety | 56.2% | derived | 2025-03-31 | n/a | gnni_publication_pack | internal_discount |
NCAV = total_current_assets - total_liabilities | NCAV per share = NCAV / weighted_avg_shares_diluted
Source Provenance
- Data Source
- Data Vault
- Data Vault Root
- D:\Projects\The Data Vault
- CIK
- 0001760542
- Company ID
- n/a
- Selected Annual Source
- D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001760542\companyfacts.json
- Selected Quarterly Source
- D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001760542\companyfacts.json
- Statement Extractor
- companyfacts-screener-v1
- View Extractor
- companyfacts-screener-v1
- Source Accession Count
- 22
- Imported At
- 2026-07-04T23:04:31+00:00
- Rendered At
- 2026-07-05T09:06:29+00:00
Run Audit
- Mary Run
- 1ec055d81d1a42a39490a83bb9e1f22f
- Mary As Of
- 2026-07-03
- Accession
- 0001558370-25-007871
- CIK
- 0001760542
- Mary Filing Date
- 2025-05-15
- Filing Currency
- USD
- Internal Discount
- 56.2%
- Source State
- Stale Filing
- Market Context
- Not Displayed
- Market Policy
- internal_only_not_redistributed
- Share Trend
- Not Evaluated
- Dilution
- Needs Review
mary_run=1ec055d81d1a42a39490a83bb9e1f22f; mary_as_of=2026-07-03; mary_filing_date=2025-05-15; mary_accession=0001558370-25-007871; mary_cik=0001760542; gnni_supporting_filing_date=2025-05-15; internal_discount=0.561705; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review